InvestorsHub Logo
Post# of 4973165
Next 10
Followers 39
Posts 7318
Boards Moderated 0
Alias Born 10/17/2013

Re: None

Monday, 02/13/2023 9:44:08 AM

Monday, February 13, 2023 9:44:08 AM

Post# of 4973165
Time for a strong recovery

RESHAPE LIFESCIENCES (RSLS): 4.4500-0.5700 (-11.35%)

Feb 13, 2023 5.3300 4.9000 4.2500 4.4500 4.4500 168,532
Feb 10, 2023 5.3300 5.4500 5.0000 5.0200 5.0200 519,700
Feb 09, 2023 5.8700 5.9200 5.3800 5.5300 5.5300 715,000
Feb 08, 2023 6.2000 8.2000 5.5700 5.9050 5.9050 5,910,000
Feb 07, 2023 6.6500 6.7280 6.0600 6.1600 6.1600 931,200
Feb 06, 2023 6.5000 7.4500 6.3500 6.9500 6.9500 5,427,300
Feb 03, 2023 13.1400 22.4000 11.5600 17.0400 17.0400 11,599,000

Total Cash (mrq) 16.35M
= $9/share.
Total Debt (mrq) 255k
Shares Outstanding 1.79M
Float 478.54k

https://www.reshapelifesciences.com/
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.